[1]
Y. Deeva and et al. co-authors, “Clinical efficacy and safety of high-dose ambroxol in the form of oromucosal spray in postnasal drip syndrome: results of a multicenter study in Ukraine”, Med. perspekt., vol. 30, no. 2, pp. 61–77, Jun. 2025.